| Literature DB >> 34768758 |
Paolo Ruzza1, Claudia Honisch1,2, Rohanah Hussain3, Giuliano Siligardi3.
Abstract
A useful tool to analyze the ligands and/or environmental contribution to protein stability is represented by the Synchrotron Radiation Circular Dichroism UV-denaturation assay that consists in the acquisition of several consecutive repeated far-UV SRCD spectra. Recently we demonstrated that the prevailing mechanism of this denaturation involves the generation of free radicals and reactive oxygen species (ROS). In this work, we analyzed the effect of buffering agents commonly used in spectroscopic measurements, including MOPS (3-(N-morpholino) propanesulfonic acid), HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), TRIS-HCl (tris-hydroxymethil aminomethane hydrochloride), and phosphate, on the efficiency of protein denaturation caused by exposure to UV radiation. Fluorescence experiments confirmed the presence of ROS and were used to determine the rate of ROS generation. Our results indicate that the efficiency of the denaturation process is strongly influenced by the buffer composition with MOPS and HEPES acting also as scavengers and that the presence of proteins itself influenced the ROS formation rate.Entities:
Keywords: photo-oxidation; protein denaturation; reactive oxygen species (ROS); spectroscopy and biochemistry buffers; synchrotron radiation circular dichroism (SRCD)
Mesh:
Substances:
Year: 2021 PMID: 34768758 PMCID: PMC8583428 DOI: 10.3390/ijms222111325
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1UV-denaturation experiments of BSAff. (A) 50 consecutive repeated scans of BSAff (6.8 µM) in 10 mM phosphate buffer, pH 7.00. (insert) Time-course of CD values at 192 nm versus scan numbers. (B) Secondary structure estimation of BSAff throughout the UV-denaturation experiment. Spectra were acquired in the 185-260 nm range at module B end station of beamline B23 at Diamond Light Source synchrotron facility, Harwell Science and Innovation Campus (Didcot, UK), using a 0.02 cm quartz cuvettes and 0.5 mg/mL (7.6 µM) protein concentration. Bandwidth was 1 nm, scan speed was 39 nm/min, and top-up mode ring current of 300 mA.
Decay rate and half-life values of UV denaturation of tested protein determined acquiring 50 consecutive repeated scans.
| Buffer | PB | TRIS | MOPS | HEPES | ||||
|---|---|---|---|---|---|---|---|---|
| Protein | k | t1/2 | k | t1/2 | k | t1/2 | k | t1/2 |
| BSAff | 37.3 ± 0.5 | 18.6 ± 0.3 | 39.2 ± 0.6 | 17.8 ± 0.2 | 31.4 ± 0.5 | 22 ± 0.4 | 28.1 ± 0.5 | 24.4 ± 0.4 |
| HSA | 25.1 ± 0.7 | 27.9 ± 0.7 | 24.3 ± 0.6 | 28.8 ± 0.6 | 20.2 ± 0.5 | 33.8 ± 0.8 | 18.4 ± 0.6 | 39.0 ± 1.0 |
| IgG | 16.3 ± 1.7 | 44.1 ± 0.9 | 17.2 ± 1.9 | 41.3 ± 0.9 | 13.2 ± 2.2 | 54.5 ± 1.4 | 11.1 ± 1.3 | 65.7 ± 0.9 |
| Ubi | 3.0 ± 0.7 | 209 ± 42 | 5.1 ± 1.1 | 130 ± 27 | 4.2 ± 0.6 | 188 ± 31 | 2.0 ± 0.6 | 292 ± 81 |
| PLL | 7.1 ± 0.9 | 93.2 ± 6.5 | 12.0 ± 0.4 | 59.7 ± 1.6 | 10.1 ± 0.7 | 68.0 ± 9.3 | 7.2 ± 0.4 | 101 ± 16 |
| HEWL | 28 ± 1.2 | 24.8 ± 0.9 | 31 ± 1.2 | 22.6 ± 0.8 | 21 ± 1.3 | 33.0 ± 1.9 | 23 ± 1.4 | 30.7 ± 1.9 |
Figure 2(A) Fluorescence emission spectra of oxidized DHR-123 in 10 mM phosphate buffer, pH 7.00. (B) Time-courses of fluorescence emission at 524 nm of oxidized DHR-123 in tested buffer solutions. A DMSO stock solution of DHR-123 was diluted in tested buffer obtaining a 3.17 µM solution (DMSO percentage less than 0.05%). Solutions were irradiated using UV-C lamps in a BioLink 254 photoreactor. Fluorescence spectra were recorded after excitation at 505 nm with a slit of 4 nm.
Oxidation rate and doubling time (dt) values of DHR-123 conversion to fluorescent Rh-123 in tested buffer solutions.
| Buffer | PB | TRIS | HEPES | MOPS | ||||
|---|---|---|---|---|---|---|---|---|
| Rate | dt | Rate | dt | Rate | dt | Rate | dt | |
| alone | 30.40 ± 0.08 | 0.21 ± 0.08 | 30.20 ± 0.06 | 0.21 ± 0.06 | 38.85 ± 0.07 | 0.16 ± 0.07 | 25.81 ± 0.06 | 0.25 ± 0.06 |
| BSAff | 38.53 ± 0.02 | 0.16 ± 0.02 | 43.37 ± 0.01 | 0.15 ± 0.01 | 33.22 ± 0.01 | 0.19 ± 0.01 | 35.41 ± 0.01 | 0.18 ± 0.01 |
| HSA * | 130.62 | 0.04 | 131.17 | 0.04 | 130.77 | 0.04 | 131.01 | 0.04 |
| HEWL | 48.91 ± 0.01 | 0.12 ± 0.01 | 43.56 ± 0.02 | 0.14 ± 0.02 | 31.42 ± 0.02 | 0.20 ± 0.02 | 24.15 ± 0.01 | 0.27 ± 0.01 |
| IgG | 56.65 ± 0.06 | 0.11 ± 0.06 | 53.46 ± 0.08 | 0.13 ± 0.08 | 42.26 ± 0.01 | 0.12 ± 0.01 | 43.91 ± 0.04 | 0.15 ± 0.04 |
| Ubi | 86.80 ± 0.50 | 0.03 ± 0.01 | 54.86 ± 0.83 | 0.06 ± 0.01 | 57.43 ± 0.02 | 0.09 ± 0.02 | 68.99 ± 0.02 | 0.09 ± 0.02 |
| PLL | 26.28 ± 0.04 | 0.23 ± 0.04 | 28.16 ± 0.02 | 0.22 ± 0.02 | 28.20 ± 0.01 | 0.22 ± 0.01 | 29.67 ± 0.04 | 0.21 ± 0.04 |
* The DHR-123 conversion in the presence of pharmaceutical HSA saturated immediately and the fluorescence data are fitted only between two points.
Figure 3Time-courses of DHR-123 conversion in 10 mM HEPES buffer, pH 7.00, in the presence of different proteins. Solutions were irradiated using UV-C lamps in a BioLink 254 photoreactor. Fluorescence spectra were recorded after excitation at 505 nm with a bandwidth of 4 nm.
Figure 4Time-courses of DHR-123 conversion in the presence of HEWL in different buffers. Solutions were irradiated using UV-C lamps in a BioLink 254 photoreactor. Fluorescence spectra were recorded after excitation at 505 nm with a bandwidth of 4 nm.